Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.
Type:
Application
Filed:
June 23, 2006
Publication date:
April 29, 2010
Applicants:
CIPHERGEN BIOSYSTMES, INC., UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Inventors:
Eric Thomas Fung, Frederick Rand Ueland, J.R. van Nagell, Paul Duane Depriest, Andre Thomas Baron